We have made an investment in Superbio.ai Inc., a start up company that is in the process building a biomedical R&D AI/ML platform. The company’s aim is to build a No-code Auto machine learning platform for Biomedical and life science R&D. Although still in its early stage, it has already built a beta version of the platform (superbio.ai) and in the process to enhance its collections of biomedical ai models and relevant data. The platform, after it is completely built, will bring public and private biomedical data repositories, easy-to-use machine learning models, automated and expert analysis, all into one place. It will make the entire machine learning models available through the apps.